Ixazomib Versus Placebo as Postinduction Maintenance Therapy in Newly Diagnosed Multiple Myeloma Patients: An Analysis by Age and Frailty Status of the TOURMALINE-MM4 Study

Authors: Bringhen, Sara, Pour, Luděk, Benjamin, Reuben, Grosicki, Sebastian, Min, Chang-Ki, C． de Farias, Danielle Leao, Vorog, Alexander, Labotka, Richard J., Wang, Bingxia, Cherepanov, Dasha, Cain, Lauren E., Manne, Sudhakar, Rajkumar, S. Vincent, Dimopoulos, Meletios A.

Source: Clinical lymphoma, myeloma & leukemia. 23(7):491-504

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100193422984.0x000001&indx=1&recIds=ETOCvdc_100193422984.0x000001

Oral ixazomib-dexamethasone versus oral pomalidomide-dexamethasone for lenalidomide-refractory, proteasome inhibitor-exposed multiple myeloma (MM) patients: A global, multicenter, randomized, open-label, phase 2 trial.

Authors: Dimopoulos, Meletios A., Schjesvold, Fredrik, Doronin, Vadim, Vinogradova, Olga, Quach, Hang, Leleu, Xavier, Yolanda, Gonzalez montes, Ramasamy, Karthik, Pompa, Alessandra, Levin, Mark-David, Lee, Cindy, Mellqvist, Ulf-Henrik, Fenk, Roland, Sati, Hamdi, Vorog, Alexander, Labotka, Richard J., Du, Jichang, Darif, Mohamed, Kumar, Shaji

Source: Journal of clinical oncology. 39(15 suppl):8020-8020

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100173216933.0x000001&indx=1&recIds=ETOCvdc_100173216933.0x000001

Measurement of intracellular pH and deoxyhemoglobin concentration in deoxygenated erythrocytes by phosphorus-31 nuclear magnetic resonance.

Authors: Labotka, Richard J.

Source: Biochemistry; November 6 1984, Vol. 23, p5549-5555, 7p

Structural determinants of substrate specificity of the erythrocyte anion transporter.

Authors: Galanter, William L., Hakimian, Michele, Labotka, Richard J.

Source: American Journal of Physiology; October 1993 pt1, Vol. 265, pC918-C926, 9p

Ammonia permeability of erythrocyte membrane studied by 14N and 15N saturation transfer NMR spectroscopy.

Authors: Labotka, Richard J., Lundberg, Peter, Kuchel, Philip W.

Source: American Journal of Physiology; March 1995 pt1, Vol. 268, pC686-C699, 14p

Aspirin acetylation of βLys-82 of human hemoglobin: NMR study of acetylated hemoglobin tsurumai

Authors: Xu, Arron S.L ^{∗, †}, Ohba, Yuzo ^‡, Vida, Loyda ^§, Labotka, Richard J ^§, London, Robert E ^{∗, *}

Source: In Biochemical Pharmacology 2000 60(7):917-922

Acetylation of Human Hemoglobin by Methyl Acetylphosphate: EVIDENCE OF BROAD REGIO-SELECTIVITY REVEALED BY NMR STUDIES

Authors: Xu, Arron S.L. ^‡, Labotka, Richard J. ^§, London, Robert E. ^{‡, ¶}

Source: In Journal of Biological Chemistry 17 September 1999 274(38):26629-26632

NMR study of the sites of human hemoglobin acetylated by aspirin

Authors: Xu, Arron S.L, Macdonald, Jeffrey M, Labotka, Richard J, London, Robert E ^*

Source: In Biochimica et Biophysica Acta (BBA)/Protein Structure and Molecular Enzymology 1999 1432(2):333-349

Progression-Free Survival (PFS) Benefit Demonstrated and Quality of Life (QoL) Maintained across Age and Frailty Subgroups with the Oral Proteasome Inhibitor (PI) Ixazomib Vs Placebo As Post-Induction Maintenance Therapy in Non-Transplant Newly Diagnosed Multiple Myeloma (NDMM) Patients (Pts): Analysis of the TOURMALINE-MM4 Phase 3 Trial

Authors: Bringhen, Sara, Pour, Luděk ^*, Benjamin, Reuben ^*, Grosicki, Sebastian, Min, Chang-Ki ^*, De Farias, Danielle Leao Cordeiro, Vorog, Alexander ^*, Labotka, Richard J, Wang, Bingxia ^*, Cherepanov, Dasha ^*, Cain, Lauren E. ^*, Manne, Sudhakar ^*, Rajkumar, S. Vincent ^*, Dimopoulos, Meletios A.

Source: In Blood 5 November 2020 136 Supplement 1:30-31

Prognostic Importance of Measurable Residual Disease (MRD) Kinetics and Progression-Free Survival (PFS) Benefit in MRD+ Patients (Pts) with Ixazomib Vs Placebo As Post-Induction Maintenance Therapy: Results from the Multicenter, Double-Blind, Phase 3 TOURMALINE-MM4 Trial in Non-Transplant Newly Diagnosed Multiple Myeloma (NDMM) Pts

Authors: Paiva, Bruno ^*, Manrique, Irene ^*, Giuliani, Nicola, Cavo, Michele ^*, Rojas, Christine ^*, Fu, Weijun ^*, Mateos, María-Victoria, Dimopoulos, Meletios A, Vorog, Alexander ^*, Li, Cong ^*, Wang, Bingxia ^*, Labotka, Richard J, Dash, Ajeeta B ^*

Source: In Blood 5 November 2020 136 Supplement 1:20-21

A phosphate-analogue probe of red cell pH using phosphorus-31 nuclear magnetic resonance.

Authors: Labotka, Richard J., Kleps, Robert A.

Source: Biochemistry; December 20 1983, Vol. 22, p6089-6095, 7p

A Phase 1 First-in-Human Study of the Anti-CD38 Dimeric Fusion Protein TAK-169 for the Treatment of Patients (pts) with Relapsed or Refractory Multiple Myeloma (RRMM) Who Are Proteasome Inhibitor (PI)- and Immunomodulatory Drug (IMiD)-Refractory, Including Pts Relapsed/Refractory (R/R) or Naïve to Daratumumab (dara)

Authors: Kumar, Shaji K., Cornell, Robert F., Landgren, Ola, Ailawadhi, Sikander, Higgins, Jack P ^*, Willert, Erin K ^*, Waltzman, Roger ^*, Lin, Jianchang ^*, Zhang, Yuhong ^*, Lublinsky, Anya R ^*, Dash, Ajeeta B ^*, Hanley, Michael ^*, Manoharan, Divya ^*, Leichter, Morgan ^*, Ottinger, Sean ^*, Labotka, Richard J, Newcomb, John ^*, Vorog, Alexander ^*

Source: In Blood 13 November 2019 134 Supplement 1:1867-1867

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Refining the value of secretory phospholipase A2 as a predictor of acute chest syndrome in sickle cell disease: results of a feasibility study ( PROACTIVE).

Authors: Styles, Lori, Wager, Carrie G., Labotka, Richard J., Smith-Whitley, Kim, Thompson, Alexis A., Lane, Peter A., McMahon, Lillian E. C., Miller, Robin, Roseff, Susan D., Iyer, Rathi V., Hsu, Lewis L., Castro, Oswaldo L., Ataga, Kenneth I., Onyekwere, Onyinye, Okam, Maureen, Bellevue, Rita, Miller, Scott T.

Source: British Journal of Haematology; Jun2012, Vol. 157 Issue 5, p627-636, 10p, 2 Diagrams, 2 Charts, 1 Graph

Subject Terms: FEASIBILITY studies, SICKLE cell anemia, PHOSPHOLIPASES, BLOOD testing, HEALTH risk assessment, LEUKOCYTES

Evaluation of the SCKnowIQ Tool and Reproductive CHOICES Intervention Among Young Adults With Sickle Cell Disease or Sickle Cell Trait.

Authors: Gallo, Agatha M., Wilkie, Diana J., Wang, Edward, Labotka, Richard J., Molokie, Robert E., Stahl, Christiane, Hershberger, Patricia E., Zhao, Zhongsheng, Suarez, Marie L., Johnson, Bonnye, Pullum, Cherese, Angulo, Rigoberto, Thompson, Alexis

Source: Clinical Nursing Research; May2006, Vol. 15 Issue 2, p421-441, 21p

A Comparison of Two Pain Assessment Tools, the Adolescent Pediatric Pain Tool and PAINReportIt and Use of the Composite Pain Index in Sickle Cell Disease

Authors: Mack, A. Kyle, Pelligra, Stephanie ^*, Labotka, Richard J., Molokie, Robert, Kim, Young O ^*, Thompson, Alexis, Wilkie, Diana J ^*

Source: In Blood 19 November 2010 116(21):2648-2648